Skip to main content

AVAI BIO, INC.

AVAI
OTC Technology Cloud & Data Services
0,32 €
▲ 0,00 € (1,25%)
Cap. Boursière: 42,58 M
Prix
0,31 €
Cap. Boursière
42,58 M
Fourchette du Jour
Fourchette 52 Semaines
Volume
Ouverture —
Moyenne 50J / 200J
Moyenne 50J / 200J

Historique des Prix

Tendances Financières

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Estimations de Bénéfices

Aucune estimation prévisionnelle disponible

No fundamental snapshot available yet.

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2022 FY2021 FY2020
Revenue 276 324,0
Net Income -1,14 M -2,13 M -126 521,0 -248 022,0 -69 593,0
EPS (Diluted)
Gross Profit -40 453,0 210 794,0 16 536,0 256 334,0
Operating Income -1,14 M -2,13 M 126 521,0 248 022,0 -69 593,0
EBITDA
R&D Expenses 27 040,0
SG&A Expenses
D&A 74 320,0 76 953,0 39 102,0
Interest Expense 921 306,0 1,21 M
Income Tax

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2022 FY2021 FY2020
Total Assets 224 745,0 322 014,0 454 664,0 868 680,0 419 971,0
Total Liabilities 1,79 M 1,79 M 860 225,0
Shareholders' Equity -1,56 M -1,47 M -405 561,0 -275 002,0 -37 686,0
Total Debt
Cash & Equivalents 81 053,0 281,0 33 289,0 60 364,0 27 301,0
Current Assets 93 133,0 116 082,0 330 872,0 672 704,0 148 363,0
Current Liabilities 1,79 M 1,79 M 860 225,0 1,14 M 419 971,0